The cytoplasm is protected against the perils of protein misfolding by two mechanisms: molecular chaperones (which facilitate proper folding) and the ubiquitin-proteasome system, which regulates degradation of misfolded proteins. CHIP (carboxyl terminus of Hsp70-interacting protein) is an Hsp70-associated ubiquitin ligase that participates in this process by ubiquitylating misfolded proteins associated with cytoplasmic chaperones. Mechanisms that regulate the activity of CHIP are, at present, poorly understood. Using a proteomics approach, we have identified BAG2, a previously uncharacterized BAG domaincontaining protein, as a common component of CHIP holocomplexes in vivo. Binding assays indicate that BAG2 associates with CHIP as part of a ternary complex with Hsc70, and BAG2 colocalizes with CHIP under both quiescent conditions and after heat shock. In vitro and in vivo ubiquitylation assays indicate that BAG2 is an efficient and specific inhibitor of CHIP-dependent ubiquitin ligase activity. This activity is due, in part, to inhibition of interactions between CHIP and its cognate ubiquitin-conjugating enzyme, UbcH5a, which may in turn be facilitated by ATP-dependent remodeling of the BAG2-Hsc70-CHIP heterocomplex. The association of BAG2 with CHIP provides a cochaperone-dependent regulatory mechanism for preventing unregulated ubiquitylation of misfolded proteins by CHIP.
The cytoplasm is protected against the perils of protein misfolding by two mechanisms: molecular chaperones (which facilitate proper folding) and the ubiquitin-proteasome system, which regulates degradation of misfolded proteins. CHIP (carboxyl terminus of Hsp70-interacting protein) is an Hsp70-associated ubiquitin ligase that participates in this process by ubiquitylating misfolded proteins associated with cytoplasmic chaperones. Mechanisms that regulate the activity of CHIP are, at present, poorly understood. Using a proteomics approach, we have identified BAG2, a previously uncharacterized BAG domaincontaining protein, as a common component of CHIP holocomplexes in vivo. Binding assays indicate that BAG2 associates with CHIP as part of a ternary complex with Hsc70, and BAG2 colocalizes with CHIP under both quiescent conditions and after heat shock. In vitro and in vivo ubiquitylation assays indicate that BAG2 is an efficient and specific inhibitor of CHIP-dependent ubiquitin ligase activity. This activity is due, in part, to inhibition of interactions between CHIP and its cognate ubiquitin-conjugating enzyme, UbcH5a, which may in turn be facilitated by ATP-dependent remodeling of the BAG2-Hsc70-CHIP heterocomplex. The association of BAG2 with CHIP provides a cochaperone-dependent regulatory mechanism for preventing unregulated ubiquitylation of misfolded proteins by CHIP.
Cell viability is constantly threatened by protein misfolding within the cytoplasm due to imprecise de novo protein folding and the consequences of oxidative and thermal stresses and conformational chain reaction events that affect protein structure. Because of the cellular inefficiencies and toxicities associated with off-pathway protein conformations, tightly regulated systems have evolved to minimize protein misfolding. The molecular chaperones constitute one component of the cytoplasmic protein quality control process. These proteins-including Hsp70, Hsp90, TRiC, and other associated proteins-assist in cotranslational folding, maintain metastable protein conformations, and repair proteins that are structurally defective. The molecular regulation and coordination of cytoplasmic folding and refolding are becoming increasingly clear (1) .
In addition to promoting proper folding, a second requirement of protein quality control mechanisms is the efficient removal of proteins that are irreversibly damaged or extremely toxic. Degradation of misfolded proteins occurs predominantly through the ubiquitin-proteasome system. For proteins that are misfolded within the endoplasmic reticulum, the protein degradation pathways are well described (2) . Less is known about degradation of misfolded proteins within the cytoplasm. Recently, the co-chaperone/ubiquitin ligase CHIP (carboxyl terminus of Hsp70-interacting protein) has been implicated in the degradation of a variety of chaperone-bound cytoplasmic proteins (3, 4) . CHIP inhibits the ATPase activity of Hsp70 (5) and has U boxdependent ubiquitin ligase activity that targets a range of chaperone substrates for proteasomedependent degradation (6, 7) . The proteins that are marked for degradation by CHIP include substrates of Hsp70 (such as the cystic fibrosis transmembrane conductance regulator, CFTR), Hsp90 (ErbB2), and nonnative misfolded proteins that bind cytoplasmic chaperones (4, (8) (9) (10) . Dimerization is a necessary step for this ubiquitin ligase activity, at least in vitro (11) . A general model has been developed which suggests that recruitment of CHIP to chaperone holocomplexes converts the chaperone machinery to a degradation-competent status to facilitate removal of misfolded proteins (6, 7, 12) . The recent demonstration that CHIP participates in the protein degradation pathway for misfolded, but not active, estrogen receptor (13) , supports this model.
What remains unclear is how chaperone holocomplexes are remodeled to regulate the activity of CHIP which, due to its constitutive expression, could be prone to ubiquitylate proteins on the proper folding pathway unnecessarily if its activity were unrestrained. In addition, it is also not certain how decisions are made by a chaperone complex to either refold or degrade a protein, a process referred to as "protein triage" (14) . To resolve these questions, we have performed mass spectrometry to determine the components of endogenous CHIP complexes. We have found that BAG2 is present in cytoplasmic chaperone complexes that contain CHIP and is an endogenous inhibitor of CHIP ubiquitin ligase activity, at least partly by interfering with CHIPubiquitin conjugating enzyme interactions, thus providing a cochaperone-dependent mechanism for regulating CHIP activity. 
Materials and Methods
Antibodies. Rabbit polyclonal anti-CHIP and anti-BAG2 antibodies were described previously (5) . Rabbit polyclonal anti-Hsc70 (SPA 816) was from Stressgen. Mouse anti-CHIP monoclonal antibody (colony 67) was produced in collaboration with the UNC Monoclonal Antibody Core Facility. Mouse CFTR R domain-specific antibody (MAB 1660) was from R&D systems and the MM13-4 anti-CFTR antibody was from Upstate. Anti-Rat-FITC and anti-mouse Texas Red fluorescent antibodies were from Molecular Probes.
Cell culture and transfection. To generate stable transfectants, pcDNA3-Myc-CHIP or pcDNA3 alone were transfected into HeLa cells cultured on 100-mm plates. 48 hours after transfection, cells were split and G418 was added at a working concentration of 400 µg/ml. Two weeks after transfection, G418-resistant colonies with isolated with cloning rings and screened for expression by Western blotting. For transient transfections, HEK293 cells were transfected with equivalent concentrations of CFTRΔF508, CHIP and BAG2 plasmids using Effectene (Qiagen) at the DNA:Effectene ratio of 1:5. Cells were lysed with RIPA buffer 24 hours after transfection, and CFTR protein levels were analyzed by SDS-PAGE followed by Western blotting.
Mass spectrometry detection of CHIPassociated proteins. HeLa cells stably expressing Myc-CHIP were cultured in 150-mm plates to confluence. Cells were lysed with RIPA buffer (50 mM Tris [pH 7.4], 150 mM NaCl, 1 mM EGTA, 0.25% sodium deoxycholate, 1% NP-40 and 1 mM sodium orthovanadate). Anti-Myc agarose (9E10, Santa Cruz Biotechnology) was added to the cell lysates. Agarose beads were then spun down at 500X g for 3 minutes and washed 5 times with RIPA buffer. 2X SDS sample buffer was added to the beads and boiled. After pulse spinning, the supernatants were loaded onto SDS-PAGE. Silver staining was performed using the Invitrogen SilverQuest kit according to standard instructions. Individual gel bands were excised according to protocols described previously (15) , and the proteins were in-gel digested and analyzed by combined mass spectrometric approaches. Briefly, the gels were subjected to trypsin proteolysis using a ProGest automated digester (Genomics Solutions). The extracted peptides were analyzed on a MALDI-TOF/TOF (Applied Biosystems) and an ESI Q-TOF (API-US Micromass) equipped with a capillary LC system from Waters. Data were submitted to the MASCOT database search engine (MatrixScience) for protein identification by peptide mass fingerprinting and sequence tag approaches.
Preparation of expression constructs. pGEX-4T-1 BAG2 was previously described (16) . Full length BAG2 was subcloned into pcDNA3-HA for mammalian expression. PCR was performed to generate BAG2 4-90 and 91-211 fragments and cloned into pcDNA3-HA and pGEX-6P-1. HisHsc70, Myc-CHIP and GST-CHIP plasmids were described previously (5).
Protein purification. Recombinant proteins were produced in BL21(DE3)RP cells (Stratagene). The cells were induced with 0.4 mM IPTG at room temperature for 5 hours. The cultures were spun down at 4ºC, dissolved in GST lysis buffer (20 mM Tris, pH 8.0, 300 mM NaCl, 2 mM EDTA and 2 mM DTT), sonicated, and cleared by centrifugation. Supernatants were incubated with glutathione-sepharose 4B beads at 4ºC for 2 hours and washed with GST lysis buffer with 0.5% Triton 4 times. In some experiments, the GST tag was cleaved with Precision protease (Amersham Biosciences) for pGEX-6P-1 constructs or thrombin for PGEX-4T-1 constructs. For purification of His-Hsc70, bacterial cultures were lysed in His-lysis buffer (50 mM Tris, pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.05% β-ME, and 1 mM benzamidine), and purified with Ni-NTAagarose beads (Qiagen). Recombinant NBD1-R, CHIP, Hsp70, Hdj2, and UbcH5a were purified as previously described (17) .
In vitro ubiquitylation reactions. In vitro ubiquitylation of CFTR NBD1-R domain was performed as described previously (17) . Briefly, 0.5 µg of purified CFTR-NBD domain was incubated with 4 µM CHIP, 0.4-20 µM BAG1 or BAG2, 2 µM Hsp70, 4 µM Hdj2, 0.3 µg purified rabbit E1 (Calbiochem), 1 mg/ml ubiquitin (Sigma), and 8 µM UbcH4 in 20 mM HEPES, pH 7.2, 100 mM KCl, 5 mM MgCl 2 , 5 mM ATP, 10 mM dithiothreitol for 3 h at 37 °C. Samples were analyzed by SDS-PAGE and blotted with anti-CFTR R domain or anti-Hsp70 antibodies. Nucleotide exchange activity. Measurement of nucleotide exchange was determined using previously described methods (5 After 15 minutes incubation at room temperature, the reactions were irradiated with an ultraviolet transilluminator for 2 minutes. Nucleotides bound to proteins were then separated from the free nucleotides by size exclusion chromatography using a G50 spin column. 1 µl of the flow through were analyzed by liquid scintillation counting.
GST pull-down assays. Glutathione-sepharosebound proteins were incubated with purified proteins for 2 hours at 4ºC with continuous rotation in GST lysis buffer. The beads were washed 4 times with GST lysis buffer containing 400 mM NaCl. Beads were then boiled in 1X SDS sample buffer and loaded on SDS-PAGE. For HisHsc70 binding assays, binding reactions were performed in His-lysis buffer with purified BAG2 and CHIP. When indicated, some experiments were performed in the absence or presence of ATP, ADP, or the non-hydrolyzable ATP analog AMP-PNP (5 mM).
Confocal microscopy. HEK293 cells transiently transfected with HA-BAG2 and Myc-CHIP or HeLa cells stably transfected with Myc-CHIP at levels similar to endogenous protein were grown on coverslips. The cells were subjected to 30 minutes of heat shock at 42 degrees, fixed with 3.7% paraformaldehyde, permeabilized with 0.5% Triton X-100, and then stained with appropriate antibodies to detect CHIP and BAG2 in the two cell types; mouse anti-Myc (9E10) and rabbit anti-HA in the HEK293 cells, and mouse anti-Myc and rabbit anti-BAG2 antisera in HeLa cells. Secondary antibodies were Alexafluor goat antimouse 488 and Alexafluor goat anti-rabbit 568. Images were acquired on an Olympus 500 Fluoroview confocal microscope. All images are at 60X magnification.
Results
Identification of CHIP-associated proteins by mass spectrometry. We created stable HeLa cell lines expressing Myc-tagged CHIP at levels approximating endogenous expression, or cells transfected with the parent vector alone ( Figure  1A ). Low-level expression of the transgene avoided CHIP-dependent induction of heat shock factor-1 (18) . Lysates from these cell lines were probed with an anti-Myc monoclonal antibody, and immunocomplexes were resolved by electrophoresis followed by silver staining to detect individual components. Representative immunocomplexes are shown in Figure 1B . Individual bands were excised and analyzed by MALDI TOF/TOF and ESI Q-TOF (15) . Consistent with previous observations, peptides representing Hsc/Hsp70 and CHIP were identified in bands of the appropriate molecular weights, indicating that CHIP associates with chaperones and homodimerizes (5, 11) . In addition, a 28-kDa band was identified that was present in approximate stoichiometry with Hsc70 in CHIP immunocomplexes. 6/6 resolvable spectra coded fragments of BAG2. Using an anti-BAG2 antibody, we confirmed that BAG2 was specifically and highly enriched in CHIP immunocomplexes ( Figure 1C ).
BAG2 is one of 6 proteins in mammals that contain the BAG domain. The BAG domain was originally identified in BAG1, a BCL2 partner protein that was subsequently confirmed to associate with Hsc70 (19, 20) . Interestingly, BAG1 has also been implicated in CHIP-dependent protein degradation (8), although we did not discover BAG1 in these experiments or in other tests for endogenous CHIP interaction partners (data not shown). BAG domain proteins possess general nucleotide exchange activities toward Hsc/Hsp70 (16) , and therefore they may each regulate chaperone activities under specific conditions. BAG2 contains the most divergent BAG domain among this family at its carboxyl terminus, and the 90 amino-proximal residues contain no motifs recognized by the SMART and PFAM algorithms. No cellular functions have been assigned to this protein to date.
We used several different approaches to characterize the interaction between CHIP and BAG2. Using GST-CHIP in pull-down assays with recombinant proteins, we found that BAG2 could be efficiently precipitated with CHIP, but only when Hsp70 was also present in the reaction (Figure 2A) . In converse experiments, GST-BAG2 precipitated CHIP in an Hsp70-dependent fashion ( Figure 2B ). Deletions of either the BAG domain (amino acids 91-211) or the amino terminal extension (amino acids 4-90) revealed that the BAG domain recruited both Hsp70 and CHIP, but with markedly lower efficiency than native BAG2, suggesting an additional role for the BAG2 amino terminus in efficient complex assembly. Finally, we used nickel chromatography to isolate recombinant proteins associating with His-tagged Hsc70. Both CHIP and BAG2 bound Hsc70 efficiently and without competition ( Figure 2C ). For reasons discussed below, it is important to note that the preceding experiments were done in the absence of ATP. Taken together they indicate the assembly of a CHIP-Hsp/Hsc70-BAG2 complex in which Hsp70 serves as a bridge linking CHIP and BAG2 and that depends on the BAG domain of BAG2. This complex appears to be further stabilized by interactions involving the amino terminus of BAG2 binding to other sites within this complex; these interactions were explored further in subsequent studies (see below).
Colocalization of BAG2 and CHIP in vivo.
CHIP has a characteristic and dynamic pattern of localization in cultured cells. Under quiescent conditions, it is localized in the cytoplasm and is strikingly concentrated at the outer membrane of the ER (5); after heat shock a significant amount of CHIP undergoes nuclear import (18) . If BAG2 regulates CHIP under endogenous conditions, then its expression and distribution after stress should mirror that of CHIP. BAG2 exhibited a similar pattern of distribution to CHIP in cultured HeLa cells and when transfected ectopically into HEK293 cells under quiescent conditions ( Figure  3 ). After heat shock, BAG2 translocated into the nucleus with temporal kinetics that mirror those of CHIP. The tight correlation of expression suggests that BAG2 and CHIP may undergo coordinated intracellular transport, perhaps as part of the same complex, and puts BAG2 in a position to regulate any of the activities so far assigned to CHIP.
BAG2 inhibits the ubiquitin ligase activity of CHIP. CHIP has two well-defined functions in regulating cytoplasmic quality control: CHIP directly activates heat shock factor-1 (which by guest on November 15, 2017 http://www.jbc.org/ Downloaded from transcriptionally regulates molecular chaperones) (18) , and CHIP is a co-chaperone/ubiquitin ligase (21) . Using a variety of assays, we did not identify any consistent affects of BAG2 on CHIPdependent heat shock factor-1 activation (data not s h o w n ). However, we found that in vitro ubiquitylation of the NBD1 domain of CFTR by CHIP was efficiently inhibited by BAG2 ( Figure  4A ). Half-maximal effects of BAG2 occurred at roughly stoichiometric concentrations of BAG2 relative to CHIP. Hsp70 itself is also a ubiquitylation target of CHIP (21), and BAG2 similarly blocked the addition of ubiquitin residues to this protein ( Figure 4B ).
We tested the specificity of this inhibitory activity by deleting the BAG domain of BAG2, which totally abolished its inhibitory activity toward CHIP (data not shown). Since BAG1 has been placed in complexes with CHIP in in vitro studies (8), we compared the activity of BAG2 with BAG1 in these assays. Even at 10-fold higher concentrations compared with BAG2, BAG1 had negligible effects on CHIP ubiquitin ligase activity ( Figure 4C ). These results are consistent with previous tests of BAG1 function (8) , and indicate that the presence of a BAG domain alone is insufficient to inhibit CHIP activity. In addition, these experiments confirm the specificity of BAG2 as an inhibitor of CHIP ubiquitin ligase activity in this assay.
To explore the effects of BAG2 in vivo, we examined its activity on a known CHIP ubiquitylation target. CHIP efficiently reduces steady state levels of the CFTRΔF508 mutant by targeting it for ubiquitin-dependent proteasomal degradation ( 4 ) . We therefore expressed CFTRΔF508 in HEK293 cells and tested the effects of CHIP and BAG2 on its expression. As has been demonstrated previously (4), CHIP reduced CFTRΔF508 levels ( Figure 4D ) . Consistent with its role in inhibiting CHIP's activity, BAG2 overcame the effects of CHIP on CFTRΔF508 and markedly increased CFTRΔF508 expression, which is under constitutive control by endogenous CHIP, both in the presence and absence of ectopic CHIP expression. In contrast, overexpression of BAG1 under similar conditions did not rescue CFTRΔF508 expression, indicating specificity for BAG2 in these studies ( Figure 4E ). These experiments are consistent with our in vitro observations and indicate that BAG2 prevents CHIP-dependent diversion of CFTRΔF508 to the proteasome-dependent quality control pathway. Interestingly, we did not identify any indication that BAG2 is itself a target for CHIP-dependent ubiquitylation under the conditions in which these in vitro and in vivo experiments were performed (data not shown).
To further characterize the participation of BAG2 in CHIP-dependent ubiquitylation, we examined the activity of the amino terminus and BAG domains of BAG2. First, we assessed the activities of BAG2 and the deletion mutants BAG2 (4-90) and BAG2 (91-211) in regulating nucleotide exchange with Hsp70. Consistent with previous observations, BAG2 inhibited nucleotide exchange with potency equivalent to BAG1 (22) , an effect that was abolished by deletion of the BAG domain but not the amino terminus of BAG2 ( Figure 5A ). We then tested the activity of the same proteins for their ability to inhibit CHIP-dependent ubiquitylation of CFTR NBD1. In contrast with its effect on nucleotide exchange, the BAG domain of BAG2 alone (BAG2 (91-211)) did not inhibit ubiquitylation of NBD1, nor did BAG1, even when present in 10-fold excess relative to CHIP ( Figure 5B ). Taken together, these results indicate that the inhibitory effects of BAG2 are not strictly due to nucleotide exchange activity, and that the amino terminus of BAG2 is required for its inhibitory effects on the ubiquitin ligase activity of CHIP.
BAG2-dependent remodeling of the CHIP ubiquitin ligase complex. Based on our current understanding of CHIP activity, we considered several plausible mechanisms for the potent antagonistic effects of BAG2. Because CHIP dimerization is required for its ubiquitin ligase activity (11), we tested whether BAG2 disrupted CHIP-CHIP dimers. To do this, we co-expressed both Myc and FLAG-tagged CHIP and used the different tags to assay CHIP dimerization by coimmunoprecipitation in cultured cells. CHIP dimers were easily detected under these conditions, and BAG2 readily incorporated into complexes containing these dimers, but (even at saturating levels of BAG2 expression) CHIP dimerization was not disrupted ( Figure 6A ). We next characterized the nucleotide dependence of the association of BAG2 and Hsp70 with CHIP by incubating GST-CHIP (or deletion mutants thereof) with recombinant BAG2 and Hsp70 and adjacent charged domains of CHIP (amino acids . When binding reactions were performed in the absence of ATP, the binding of BAG2 to CHIP followed the same binding rules as does Hsp70, which is consistent with observations in Figure 2 . Surprisingly, in the presence of ATP, a lower affinity interaction of BAG2 with the Ubox domain of CHIP was also observed that was independent of Hsp70 binding. Concomitant with this association, we found that BAG2 was released from Hsp70 in preformed Hsp70-BAG2-CHIP complexes by adenine nucleotides in binding assays of recombinant proteins using GST-BAG2; however, only ATP (and not ADP or the nonhydrolyzable ATP analog AMP-PNP) caused retention of CHIP in the Hsp70-depleted GST-BAG2 complexes ( Figure 6C ). The nucleotide dependence of this reaction raised the question of which of these proteins bound to ATP. We tested this by 8-azido-ATP photolabeling, a sensitive index of ATP binding ( Figure 6D ). As expected, ATP photoreacted with Hsp70, but not with CHIP or BAG2. Similar results were observed with ATP affinity chromatography (not shown). Taken together, these observations provided further evidence that direct interactions between BAG2 and CHIP occur. This remodeling of the Hsp70-BAG2-CHIP heterocomplex requires nucleotide binding to dissociate BAG2 from Hsp70 and (based on the effects of AMP-PNP) Hsp70-dependent nucleotide hydrolysis to facilitate the BAG2-CHIP interaction.
The release of Hsp70 from BAG2-CHIP complexes in the presence of ATP, as indicated in Figure 6C , suggested that one mechanism to account for inhibition of CHIP by BAG2 is through dissociation of Hsp70 that is required for substrate presentation to CHIP. We therefore performed additional binding assays under the same conditions as our in vitro ubiquitylation reactions (Figure 4 ) in an ATP-containing system. Under these conditions, and in contrast to the effects in the absence of ATP (see Figure 2) , BAG2 disrupted the association between CHIP and Hsp70 ( Figure 7A ) in a concentrationdependence that was analogous to its effect on CHIP ubiquitin ligase activity ( Figure 4A ). In contrast, and in spite of the fact that it has equivalent effects on Hsp70 nucleotide exchange ( Figure 5A ), BAG1 had little effect on CHIPHsp70 interactions, even at relatively high molar ratios ( Figure 7B ). Consistent with this observation, BAG1 did not "rescue" CHIP from BAG2-dependent suppression of its ubiquitin ligase activity in in vitro assays (data not shown). We also found that BAG2 disrupted the association of CHIP and endogenous Hsc/Hsp70 in vivo ( Figure 7C) . By disrupting the ability of Hsp70 to present substrates to CHIP, this ATPdependent remodeling of the CHIP complex would have the expected effect of inhibiting its ubiquitin ligase activity toward substrates, as we observe in our in vitro and in vivo studies (Figure 4 ).
BAG2 disrupts CHIP E2-E3 coupling.
Given the indications of discrete contacts between BAG2 and the U-box of CHIP in these complexes ( Figure  6B ), we further considered whether other aspects of ubiquitin ligase complex assembly were perturbed when BAG2 was present in these complexes. We have previously observed that stable interactions between CHIP and the ubiquitin conjugating enzyme UBCH5a are necessary for ubiquitin ligase activity (21) . Incorporation of BAG2 into CHIP complexes in the presence of ATP destabilized this interaction ( Figure 8A ), preventing E2-E3 coupling that is required for ubiquitin chain assembly. Similarly, UbcH5a reversed BAG2-dependent stabilization of CFTRΔF508, and competitively released BAG2 from CHIP immunocomplexes in HEK293 cells ( Figure 8B ), which supports a model in which UbcH5a and Bag2 compete (directly or indirectly) for binding to the U-box of CHIP. Given the proximity of BAG2 and CHIP within the chaperone/ubiquitin ligase holocomplex, this activity provides an additional mechanism for inhibition of chaperone substrate ubiquitylation. Taken together, our observations suggest that BAG2 exerts a checkpoint mechanism that may prevent dysregulated ubiquitylation of chaperone substrates.
Discussion
Molecular chaperones require coordinated interactions with multiple co-chaperones to regulate the steps in protein folding. We have speculated that chaperone-dependent protein degradation is regulated with equivalent precision. Based on the growing appreciation for the role of CHIP in chaperone-dependent protein degradation, we immunopurified endogenous CHIP complexes with the goal of identifying the range of proteins that regulate the CHIP-Hsp70 complex. BAG2 is a prominent component of CHIP-containing holocomplexes, suggesting that it plays an endogenous role in regulating diversion of chaperone substrates to the ubiquitin-proteasome pathway for degradation.
BAG2 is one among 6 mammalian proteins containing carboxy-terminal BAG domains. Many of the BAG-domain proteins possess antiapoptotic activities (although presumably through nonoverlapping mechanisms) (16, 23) and all of them interact with the ATPase domain of Hsc70 in a BAG-domain-dependent mechanism (22) . It seems most likely that the principal biochemical effect of BAG-Hsc70 interactions is to facilitate nucleotide exchange (24, 25) , although analyses of BAG1 suggest that nucleotide exchange may not comprise the entirety of BAG domain protein activities toward Hsp70 (26) . Nevertheless, the consequences of BAG-domain protein effects on Hsp70 can be modulated both by stoichiometric considerations and by structural features within the amino terminal extension adjacent to the BAG domain (27, 28) . It has been proposed that BAGdomain proteins undergo conformational regulation that coordinates interactions among partner proteins (16) , an effect that at least in some cases is ATP-dependent (28) . Our data indicate that BAG2 is a major component of the Hsc70-CHIP chaperone-dependent ubiquitin ligase complex, and our observation that amino-terminus sequences in BAG2 stabilize the ternary BAG2-Hsc70-CHIP complex ( Figure 2B ) suggests that these sequences may form protein-protein interactions within this complex-in addition to the BAG-ATPase domain interaction-to tune the molecular functions of this complex. Consistent with this model, BAG2 directly interacts with the U-box domain of CHIP in an ATP-dependent fashion ( Figure 6B ) and remodels these complexes such that Hsp70 is excluded (Figure 7) . The ability of BAG2 (but not BAG1) to suppress UbcH5a interactions with CHIP (Figure 8 ) raises the interesting possibility that the amino terminus of BAG2 sterically hinders this association, although at the present time we cannot exclude the possibility that BAG2 also has conformational effects on the complex that determine the rules of E2-E3 association (Figure 9 ).
The present studies provide an important basis for beginning to understand how decisions about protein triage are made at the level of individual chaperone complexes. Until now, no mechanism has existed to explain how CHIP is prevented from ubiquitin-tagging proteins on the proper folding pathway for degradation. Our results indicate that BAG2 is likely to play a constitutive regulatory role in this decision. The close intracellular colocalization of CHIP and BAG2 under conditions of quiescence and thermal challenge suggests that coordination of CHIP activity by BAG2 is an ongoing process within the cell (Figure 3 ). How this association is regulated is an open question at this time, although our data indicate that BAG2 interactions are clearly nucleotide-dependent. It is also likely that other events regulate the activity of this complex. In this regard, it is interesting to note that BAG2 was identified in an inductive proteomic screen for targets of p38 MAP kinase activity (29) . However, we did not find that the effects of BAG2 on CHIP were altered by pharmacologic inhibitors or activators of p38 (data not shown). It is also plausible that other proteins compete for the ability of BAG2 to join CHIPHsp70 complexes-an analogous competition between BAG1, Raf-1, and Hsp70 has been proposed to coordinate stress signaling and mitogenic responses (30).
Interestingly, BAG2 is not the first BAG domain protein that has been implicated in CHIPdependent protein degradation. BAG1 has been suggested to cooperate with CHIP by facilitating transfer of proteins ubiquitylated by CHIP to the proteasome (8) . This activity of BAG1 is dependent on associations of the proteasome with a ubiquitin-like domain at the amino terminus of BAG1 that is not present in BAG2. We have not detected endogenous complexes containing both CHIP and BAG1 in our studies, which may only indicate that this association is tightly regulated. It is interesting to speculate that serial interactions among BAG proteins regulate the CHIP-Hsp70 of BAG1 compared with BAG2 we observed ( Figure 7 ) would argue that this might occur only under specific circumstances. In any event, our data indicate that BAG domain-containing proteins, and BAG2 specifically, provide a plausible mechanism to regulate the activity of Hsp70-CHIP complexes and therefore to govern the balance between folding and degradation of misfolded proteins. 
